Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:03 PM ET 10-Q
Financial Results VirTra, Inc VTSI

VirTra Q3 2026 Results: Turns Profitable, Net Income $2.16M

For the quarter ended September 30, 2026, VirTra reported net sales of $7.6 million, a significant increase from $5.3 million in the prior year period, resulting in a net income of $2.16 million. However, for the nine-month period, net sales decreased to $16.8 million compared to $19.5 million in 2025, reflecting fluctuations in contract timing.

Key figure
Net income $2.16M
4:03 PM ET 8-K
Loan & Debt Linde PLC LIN

Linde Debt Financing Update with Citigroup Global Markets Limited

Linde plc issued €1.3 billion in aggregate principal amount of senior notes, consisting of €650 million of 3.700% notes due 2029 and €650 million of 4.000% notes due 2033. The notes were issued under the company's €25 billion European debt issuance programme and are guaranteed by subsidiaries Linde GmbH and Linde Inc. Net proceeds of approximately €1,295 million will be used for general corporate purposes.

Counterparty
Citigroup Global Markets Limited
Term
through 2033
4:03 PM ET 10-Q
Financial Results Mannatech Inc MTEX

Mannatech Q3 2026 Results: Net Income $8.9M, Up 362.8% YoY

For the nine months ended September 30, 2026, Mannatech reported net sales of $76.4 million and a net income of $10.9 million, a significant recovery from a $3.9 million net loss in the prior year period. This improvement was primarily driven by a $10.5 million income tax benefit and reduced operating expenses, despite a decline in overall net sales.

Key figure
Net income $8.9M · +362.8% YoY
4:03 PM ET 8-K
Financial Results VirTra, Inc VTSI

VirTra Financial Results

VirTra reported Q3 2026 financial results featuring a 42% year-over-year revenue increase to $7.6 million and a return to profitability with net income of $2.2 million. The company highlighted strong bookings of $10.3 million and a total backlog of $27.6 million, supported by new contract awards from U.S. Customs and Border Protection and the U.S. Army.

Term
Q3 2026

“Our third quarter results reflect continued improvement across the business, highlighted by strong revenue growth, accelerating bookings, and improved profitability. We are particularly encouraged by the acceleration in customer orders, which, together with our improving revenue performance, provides tangible evidence that demand is translating into business results.”

John Givens, CEO

“We are also seeing encouraging developments in the government funding environment. Following nearly two years of limited grant activity, funding programs are reopening and customers are actively pursuing new opportunities.”

John Givens, CEO
4:03 PM ET 8-K
Financial Results Applied Materials Inc AMAT

Applied Materials Financial Results

Applied Materials reported record fourth quarter and fiscal year 2026 results, with quarterly revenue surging 53% year-over-year to $10.41 billion. The company achieved record annual revenue of $34.45 billion and record non-GAAP EPS of $12.89, driven by strong AI-related demand for semiconductors. Management highlighted that the company is on track to grow its Semiconductor Systems business by more than 40% in calendar 2026.

Term
FY2026

“Applied Materials delivered record results in fiscal 2026, and we are on track to grow our Semiconductor Systems business more than 40 percent in our calendar 2026. AI continues to fuel strong incremental demand for semiconductors and Applied has built the most-enabling portfolio to advance the AI-computing roadmap, putting us in a great position for multi-year revenue and profit growth.”

Gary Dickerson, President and CEO

“With technology leadership in the most critical areas of the wafer fab equipment market, Applied Materials increased fiscal fourth quarter revenue by 53 percent year over year and non-GAAP earnings per share by 92 percent. We generated record quarterly free cash flow of $2.6 billion and distributed over $2.4 billion to shareholders, including the largest quarterly share buyback in more than eight years.”

Brice Hill, Senior Vice President and CFO
4:03 PM ET 8-K
Financial Results Heartflow, Inc. HTFL

Heartflow Financial Results

Heartflow reported Q3 2026 revenue of $72.9 million, a 57% year-over-year increase driven by strong U.S. case volume for its FFRCT and Plaque Analysis products. The company significantly raised its full-year 2026 revenue guidance to a range of $262 million to $264 million, citing rapid CCTA market growth and improved production efficiency.

Term
Q3 2026

“Our third quarter was excellent, with revenue accelerating for the third consecutive quarter and U.S. revenue growing at its fastest pace in 11 quarters. Our core FFRCT business remains durable, our installed base continues to expand rapidly, and activations of Heartflow Plaque Analysis are ramping ahead of plan, with utilization broadening across a wider share of applicable CCTAs.”

John Farquhar, President and CEO of Heartflow

“Strong performance across our diagnostic platform, along with disciplined execution of our commercial, innovation and clinical initiatives, gives us the confidence to raise our 2026 guidance once again. With continued momentum and a scaling business, we believe we are well-positioned to extend our market leadership, and we have increased confidence in our path to profitability.”

John Farquhar, President and CEO of Heartflow
4:03 PM ET 10-K
Financial Results Arrowhead Pharmaceuticals, Inc. ARWR

Arrowhead Pharmaceuticals FY 2026 Results: Net Loss of $724M, Loss Widens

Arrowhead Pharmaceuticals reported significant revenue from collaborations with Novartis ($89.0 million) and Madrigal ($25.0 million) in fiscal 2026, while total R&D expenses rose 22% to $739.1 million due to pipeline progression. A major one-time operating expense of $215.0 million was recorded for the acquisition of a Priority Review Voucher to accelerate the plozasiran sNDA.

Key figure
Net loss $724M
4:03 PM ET 10-K
Financial Results Macom Technology Solutions Holdings, Inc. MTSI

Macom Technology Solutions Holdings FY 2026 Results: Turns Profitable, Net Income $335M

MACOM Technology Solutions Holdings, Inc. identifies significant risks related to environmental compliance, data privacy (GDPR, CCPA, CPRA), and the evolving legal landscape of AI technologies. The company also highlights stock price volatility, noting a 44.2% cumulative decline in mid-2026, and warns of potential dilution from future capital-raising activities.

Key figure
Net income $335M
4:03 PM ET 10-Q
Financial Results GeoVax Labs, Inc. GOVX

GeoVax Labs Q3 2026 Results: Net Loss of $4.16M, Loss Narrows

GeoVax Labs, Inc. reported a net loss of $13.8 million for the nine months ended September 30, 2026, compared to $17.0 million in the prior year period. The company is prioritizing its GEO-MVA vaccine candidate for poxviruses and its Gedeptin oncology program, though both require additional financing to initiate upcoming Phase 3 and Phase 2 trials, respectively.

Key figure
Net loss $4.16M
4:03 PM ET Form 4
Insider Selling Assurant, Inc. AIZ

Assurant EVP, Pres, Global Conn Living Nair Biju Sells $1.05M of Stock

Nair Biju, EVP, Pres, Global Conn Living, sold 3,272 shares of Assurant, Inc. at $319.84 a share, worth $1.05M in total on Nov 10, 2026. Shares held after the trade: 20,975 (-13.5%).

Value
$1.05M
Shares
3,272
Price
$319.84
Role
EVP, Pres, Global Conn Living
Holding change
-13.5%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Ewsb Bancorp, Inc. EWSB

Ewsb Bancorp Q3 2026 Results: Net Loss of $114K, Loss Narrows

EWSB Bancorp reported a net loss of $113,655 for the third quarter of 2026, an improvement from a $3.34 million loss in the prior year period which was impacted by a large tax provision. The company strengthened its capital position during the quarter through a stock offering and the issuance of preferred shares, totaling approximately $774,829 in net proceeds.

Key figure
Net loss $114K
4:02 PM ET 10-Q
Financial Results Vireo Growth Inc. VREOF

Vireo Growth Q3 2026 Results: Net Loss of $24M, Loss Narrows

Vireo Growth Inc. reported a significant revenue increase to $253.7 million for the quarter ended September 30, 2026, compared to $91.7 million in the prior year, driven by multiple acquisitions including Eaze, Hawthorne, and C21. Despite higher gross profits, the company recorded a net loss of $24.0 million for the quarter, impacted by substantial current income tax expenses and transaction-related costs.

Key figure
Net loss $24M
4:02 PM ET 10-Q
Financial Results Lifeway Foods, Inc. LWAY

Lifeway Foods Q3 2026 Results: Net Income $260K, Down 92.6% YoY

Lifeway Foods reported a significant increase in net sales to $197.7 million for the nine months ended September 30, 2026, compared to $157.1 million in the prior year. However, net income decreased to $5.1 million from $11.3 million year-over-year, primarily driven by higher cost of goods sold and increased selling expenses, including a substantial rise in advertising costs.

Key figure
Net income $260K · -92.6% YoY
4:02 PM ET 8-K
Financial Results Smith Micro Software, Inc. SMSI

Smith Micro Software Financial Results

Smith Micro Software reported Q3 2026 revenue of $5.0 million, a 16% sequential increase and a year-over-year improvement from $4.3 million. The company achieved a five-year high gross margin of 81.6% and significantly narrowed its GAAP net loss to $1.7 million compared to $5.2 million in the prior year's quarter.

Term
Q3 2026

“Our third quarter marked our third consecutive quarter of sequential revenue growth as we continued to build on the momentum established in the first half of the year. Revenue increased 16% sequentially and gross margin rose to 81.6%, a five-year high.”

William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro

“Our pipeline continues to grow and yield high-quality opportunities, and I am confident in our ability to translate this momentum into long-term growth.”

William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro
4:02 PM ET 8-K
Financial Results Andersen Group Inc. ANDG

Andersen Group Financial Results

Andersen Group reported Q3 2026 revenue of $337.3 million, an 18.7% increase year-over-year, driven by broad-based growth across all service lines and geographic regions. The company reported GAAP net income of $68.0 million and introduced full-year 2027 revenue guidance of $1.275 billion to $1.325 billion.

4:02 PM ET Form 4
Insider Selling Clean Energy Fuels Corp. CLNE

Clean Energy Fuels Director Andrew J. Littlefair Sells $184K of Stock

Andrew J. Littlefair, Director, sold 100,000 shares of Clean Energy Fuels Corp. at $1.84 a share, worth $184K in total on Nov 10, 2026. Shares held after the trade: 1,882,832 (-5.0%).

Value
$184K
Shares
100,000
Price
$1.84
Role
Director
Holding change
-5.0%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Legacy Education Inc. LGCY

Legacy Education Q1 2026 Results: Net Income $869K, Down 60.3% YoY

Legacy Education Inc. reported total assets of $86.9 million as of September 30, 2026, compared to $78.5 million at the end of the prior fiscal year. The company's stockholders' equity increased to $54.0 million, driven by growth in retained earnings and additional paid-in capital.

Key figure
Net income $869K · -60.3% YoY
4:02 PM ET 10-Q
Financial Results Advanced Biomed Inc. ADVB

Advanced Biomed Q1 2026 Results: Net Loss of $989K, Loss Widens

Advanced Biomed Inc. reported a net loss of $989,054 for the quarter ended September 30, 2026, as it transitioned from biotechnology to AI and financial software activities. The company's cash position decreased to $213,995, and it recognized a significant provision for credit losses of $612,636 during the period.

Key figure
Net loss $989K
4:02 PM ET Form 4
Insider Buying Alnylam Pharmaceuticals, Inc. ALNY

Alnylam Pharmaceuticals Insider Amy W. Schulman Buys $300K of Stock

Amy W. Schulman bought 1,910 shares of Alnylam Pharmaceuticals, Inc. at $156.82 a share, worth $300K in total on Nov 9, 2026. Shares held after the trade: 25,959 (+7.9%).

Value
$300K
Shares
1,910
Price
$156.82
Holding change
+7.9%
Trade date
Nov 9, 2026
4:02 PM ET Form 4
Insider Selling Applied Optoelectronics, Inc. AAOI

Applied Optoelectronics CFO Stefan J. Murry Sells $195K of Stock

Stefan J. Murry, CFO, sold 4,000 shares of Applied Optoelectronics, Inc. at $48.83 a share, worth $195K in total on Nov 10, 2026. Shares held after the trade: 353,223 (-1.1%).

Value
$195K
Shares
4,000
Price
$48.83
Role
CFO
Holding change
-1.1%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Pluri Inc. PLUR

Pluri Q1 2026 Results: Net Loss of $10.4M, Loss Widens

Pluri Inc. reported a significant increase in net loss to $15.39 million for the quarter ended September 30, 2026, primarily driven by a $10.9 million charge for acquired in-process research and development related to the Fishway Transaction. Despite the loss, revenues grew to $759,000 compared to $316,000 in the prior year, and the company successfully raised capital through share issuances and a SAFE agreement.

Key figure
Net loss $10.4M
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $65.9K of Stock

Jurgi Camblong, Executive Chairman, sold 8,500 shares of SOPHiA Genetics SA at $7.76 a share, worth $65.9K in total on Nov 10, 2026. Shares held after the trade: 3,378,650 (-0.3%).

Value
$65.9K
Shares
8,500
Price
$7.76
Role
Executive Chairman
Holding change
-0.3%
Trade date
Nov 10, 2026
4:02 PM ET 10-Q
Financial Results Avalanche Treasury Corp AVAT

Avalanche Treasury Q3 2026 Results: Turns Profitable, Net Income $54.6M

Avalanche Treasury Corporation reported a net loss of $16.8 million for the nine months ended September 30, 2026, despite a profitable third quarter with net income of $54.6 million driven by changes in the fair value of digital assets. The company's balance sheet shows significant holdings in AVAX and USDC, with total assets decreasing from $190.9 million at year-end 2025 to $151.9 million.

Key figure
Net income $54.6M
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Insider Kathy L. Hibbs Sells $48.5K of Stock

Kathy L. Hibbs sold 6,250 shares of SOPHiA Genetics SA at $7.76 a share, worth $48.5K in total on Nov 10, 2026. Shares held after the trade: 90,742 (-6.4%).

Value
$48.5K
Shares
6,250
Price
$7.76
Holding change
-6.4%
Trade date
Nov 10, 2026
4:02 PM ET 8-K
Executive Compensation Frontdoor, Inc. FTDR

Frontdoor Executive Compensation

Frontdoor, Inc. has appointed Mary Hopkins as Vice President, Controller and Chief Accounting Officer, effective December 14, 2026. Her compensation package includes an annual base salary of $415,000, a 50% target bonus, a $250,000 sign-on cash bonus, and a $250,000 sign-on equity grant in restricted stock units.

Counterparty
Mary Hopkins
4:02 PM ET 8-K
Other 8-K Filing JAB Acquisition Corp I ATLQ

Atlantic Acquisition Corp I Other 8-K Filing

Atlantic Acquisition Corp I (formerly JAB Acquisition Corp I) held an Extraordinary General Meeting where shareholders approved a formal name change and the adoption of amended and restated Memorandum and Articles of Association. The name change became effective on November 9, 2026, and the company's trading symbols on Nasdaq remain ATLQ, ATLQU, ATLQW, and ATLQR.

4:02 PM ET Form 4
Insider Selling TheRealReal, Inc. REAL

TheRealReal CFO Gopal Ajay Madan Sells $1.04M of Stock

Gopal Ajay Madan, CFO, sold 71,027 shares of TheRealReal, Inc. at $14.65 a share, worth $1.04M in total on Nov 11, 2026. Shares held after the trade: 1,037,833 (-6.4%).

Value
$1.04M
Shares
71,027
Price
$14.65
Role
CFO
Holding change
-6.4%
Trade date
Nov 11, 2026
4:02 PM ET 10-Q
Financial Results Bank of the James Financial Group Inc BOTJ

Bank of the James Financial Group Q3 2026 Results: Net Income $3.32M, Up 20.7% YoY

Bank of the James Financial Group reported net income of $9.34 million for the first nine months of 2026, a significant increase from $6.30 million in the same period of 2025, driven by higher net interest income. Total assets grew to $1.06 billion, though stockholders' equity slightly decreased to $78.4 million due to an increase in accumulated other comprehensive loss from unrealized losses on available-for-sale securities.

Key figure
Net income $3.32M · +20.7% YoY
4:02 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CLO Well Daan Van Sells $10.5K of Stock

Well Daan Van, CLO, sold 1,411 shares of SOPHiA Genetics SA at $7.44 a share, worth $10.5K in total on Nov 9, 2026. Shares held after the trade: 331,305 (-0.4%).

Value
$10.5K
Shares
1,411
Price
$7.44
Role
CLO
Holding change
-0.4%
Trade date
Nov 9, 2026
4:02 PM ET 10-Q
Financial Results Noble Romans Inc NROM

Noble Romans Q3 2026 Results: Net Income $84.7K, Down 84.7% YoY

Noble Roman's reported total revenue of $11.27 million for the nine months ended September 30, 2026, a slight increase from the prior year, though net income decreased from $882,839 to $396,072. The company successfully refinanced its debt, moving the majority of its senior loan obligations from current to long-term liabilities.

Key figure
Net income $84.7K · -84.7% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.